SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891092-07-000732
Filing Date
2007-03-02
Accepted
2007-03-02 14:39:08
Documents
2
Period of Report
2007-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e26480_8k.txt 8-K 6564
2 PRESS RELEASE e26480ex99_1.txt EX-99.1 1292
  Complete submission text file 0000891092-07-000732.txt   9747
Mailing Address 1428 BRICKELL AVE STE 105 MIAMI FL 33131
Business Address 1428 BRICKELL AVENUE SUITE 105 MIAMI FL 33131 3054468661
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27836 | Film No.: 07667201
SIC: 8741 Services-Management Services